These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38391663)

  • 1. Reversing the Natural Drug Resistance of Gram-Negative Bacteria to Fusidic Acid via Forming Drug-Phospholipid Complex.
    Liu J; Lai X; Li Y; Yu Z; Wang X; Zhang C; Peng Q
    Bioengineering (Basel); 2024 Feb; 11(2):. PubMed ID: 38391663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a ferulic acid-phospholipid complex to improve solubility, dissolution, and B16F10 cellular melanogenesis inhibition activity.
    Li L; Liu Y; Xue Y; Zhu J; Wang X; Dong Y
    Chem Cent J; 2017 Mar; 11(1):26. PubMed ID: 29086815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of polycationic micelles as an efficient delivery system of antibiotics for overcoming the biological barriers to reverse multidrug resistance in Escherichia coli.
    Guo R; Li K; Qin J; Niu S; Hong W
    Nanoscale; 2020 May; 12(20):11251-11266. PubMed ID: 32412567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile.
    Garcia Chavez M; Garcia A; Lee HY; Lau GW; Parker EN; Komnick KE; Hergenrother PJ
    ACS Infect Dis; 2021 Feb; 7(2):493-505. PubMed ID: 33522241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Cryptic Clostridial Peptide That Kills Bacteria by a Cell Membrane Permeabilization Mechanism.
    Szadkowska M; Olewniczak M; Kloska A; Jankowska E; Kapusta M; Rybak B; Wyrzykowski D; Zmudzinska W; Gieldon A; Kocot A; Kaczorowska AK; Nierzwicki L; Makowska J; Kaczorowski T; Plotka M
    Microbiol Spectr; 2022 Oct; 10(5):e0165722. PubMed ID: 36094301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phospholipid complex to improve the oral bioavailability of flavonoids.
    Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
    Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid Complexation for Bioavailability Improvement of Albendazole: Preparation, Characterization and In Vivo Evaluation.
    Liu L; Nie J; Li L
    AAPS PharmSciTech; 2023 Jan; 24(1):36. PubMed ID: 36635447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of positively charged carbon quantum dots without detectable resistance for wound healing with mixed bacteria infection.
    Hao X; Huang L; Zhao C; Chen S; Lin W; Lin Y; Zhang L; Sun A; Miao C; Lin X; Chen M; Weng S
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111971. PubMed ID: 33812599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement of fatty acids, fatty acid analogues, and bile acids across phospholipid bilayers.
    Kamp F; Hamilton JA; Kamp F; Westerhoff HV; Hamilton JA
    Biochemistry; 1993 Oct; 32(41):11074-86. PubMed ID: 8218171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of lipopolysaccharide and phospholipid in mixed membranes: solid-state 31P-NMR spectroscopic and microscopic investigations.
    Nomura K; Inaba T; Morigaki K; Brandenburg K; Seydel U; Kusumoto S
    Biophys J; 2008 Aug; 95(3):1226-38. PubMed ID: 18456825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
    Singh C; Bhatt TD; Gill MS; Suresh S
    Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction, mechanism, and antibacterial resistance insight into polypeptide-based nanoparticles.
    Zhen JB; Zhao MH; Ge Y; Liu Y; Xu LW; Chen C; Gong YK; Yang KW
    Biomater Sci; 2019 Oct; 7(10):4142-4152. PubMed ID: 31364616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation.
    Ahmed IS; Elnahas OS; Assar NH; Gad AM; El Hosary R
    Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32106544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
    Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of high concentrations of carvedilol against Gram-positive and Gram-negative bacteria.
    Zawadzka K; Bernat P; Felczak A; Różalska S; Lisowska K
    Int J Antimicrob Agents; 2018 Mar; 51(3):458-467. PubMed ID: 29277530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
    Dombach JL; Quintana JLJ; Detweiler CS
    mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
    Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity.
    Omolo CA; Kalhapure RS; Agrawal N; Rambharose S; Mocktar C; Govender T
    Mol Pharm; 2018 Aug; 15(8):3512-3526. PubMed ID: 29953816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.